Dr Louise Sigfrid
ERGO Clinical Research Fellow
Louise Sigfrid is a Clinical Research Fellow and Public Health Specialist, with a main focus to strengthen preparedness to (re-) emerging infectious diseases through clinical research and capacity building.
Louise main focus is the PREPARE (Platform for European Preparedness Against (Re-) emerging Epidemics) project, studying incidence risk factors and clinical impact of infections with epidemic potential in Europe with a focus on acute respiratory infections, central nervous system infections, arbovirus and haemorrhagic fever syndromes in hospitalized and primary care patients.
Additionally, Louise supports the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) developing harmonised clinical research tools for characterization of emerging infections globally, including COVID-19.
Louise is lead for the Masters module in Health Protection at Brighton & Sussex Medical School and Honorary Academic Public Health Consultant at PHE.
Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study
Sigfrid L., (2023), EClinicalMedicine
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Goldswain H. et al, (2023), Genome Biol, 24
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
McAuley HJC. et al, (2023), EClinicalMedicine, 57
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
Kartsonaki C. et al, (2023), Int J Epidemiol
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs
Rigby I. et al, (2023), The Lancet Infectious Diseases